Platelet additive solution - Electrolytes

被引:19
作者
Azuma, Hiroshi [1 ]
Hirayama, Junichi [1 ]
Akino, Mitsuaki [1 ]
Ikeda, Hisami [1 ]
机构
[1] Hokkaido Red Cross Blood Ctr, Nishi Ku, Sapporo, Hokkaido 0630002, Japan
关键词
Additive solution; Low plasma concentration; Preservation capacity; Electrolyte; SOLUTION M-SOL; IN-VITRO; STORAGE; MAGNESIUM; PLASMA; POTASSIUM; GLYCOPROTEINS; REDUCTION; MEMBRANE; CALCIUM;
D O I
10.1016/j.transci.2011.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent attention to solutions that replace most or all plasma in platelet concentrates, while maintaining satisfactory platelet function, is motivated by the potential of plasma reduction or depletion to mitigate various transfusion-related adverse events. This report considers the electrolytic composition of previously described platelet additive solutions, in order to draw general conclusions about what is required for platelet function and longevity. The optimal concentrations of Na(+) and Cl(-) are 69-115 mM. The presence of both K(+) and Mg(2+) in platelet suspension at nearly physiological concentrations (3-5 mM and 1.5-3 mM, respectively) is indispensable for good preservation capacity because both electrolytes are required to prevent platelet activation. In contrast to K(+) and Mg(2+), Ca(2+) may not be important because no free Ca(2+) is available in M-sol, which showed excellent platelet preservation capacity at less than 5% plasma concentration. The importance of bicarbonate (approximately 40 mM) can be recognized when the platelets are suspended in additive solution under less than 5% residual plasma concentration. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 29 条
[1]  
ADAMS GA, 1986, BLOOD, V67, P672
[2]   Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol) [J].
Azuma, Hiroshi ;
Hirayama, Junichi ;
Akino, Mitsuaki ;
Miura, Reiko ;
Kiyama, Yoshio ;
Imai, Kiyotoshi ;
Kasai, Masaharu ;
Koizumi, Kazuki ;
Kakinoki, Yasutaka ;
Makiguchi, Yusuke ;
Kubo, Koji ;
Atsuta, Yoshiko ;
Fujihara, Mitsuhiro ;
Homma, Chihiro ;
Yamamoto, Sadamitsu ;
Kato, Toshiaki ;
Ikeda, Hisami .
TRANSFUSION, 2009, 49 (02) :214-218
[3]  
Bara M, 1984, Magnesium, V3, P215
[4]  
BOLIN RB, 1981, J LAB CLIN MED, V98, P500
[5]   Platelets stored in a new-generation container - Differences between plasma and platelet additive solution II [J].
de Wildt-Eggen, J ;
Schrijver, JG ;
Smid, WM ;
Joie, M ;
Bollinne, V ;
Bins, M .
VOX SANGUINIS, 1998, 75 (03) :218-223
[6]   Storage of platelets in additive solutions: effects of magnesium and/or potassium [J].
de Wildt-Eggen, J ;
Schrijver, JG ;
Bins, M ;
Gulliksson, H .
TRANSFUSION, 2002, 42 (01) :76-80
[7]   In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution [J].
Diedrich, B. ;
Sandgren, P. ;
Jansson, B. ;
Gulliksson, H. ;
Svensson, L. ;
Shanwell, A. .
VOX SANGUINIS, 2008, 94 (02) :96-102
[8]  
GAWAZ M, 1994, THROMB HAEMOSTASIS, V72, P912
[9]   PLATELET MEMBRANE GLYCOPROTEINS - ALTERATION DURING STORAGE OF HUMAN PLATELET CONCENTRATES [J].
GEORGE, JN .
THROMBOSIS RESEARCH, 1976, 8 (05) :719-724
[10]   Storage of platelets in additive solutions:: a multicentre study of the in vitro effects of potassium and magnesium [J].
Gulliksson, H ;
AuBuchon, JP ;
Cardigan, R ;
van der Meer, PF ;
Murphy, S ;
Prowse, C ;
Richter, E ;
Ringwald, J ;
Smacchia, C ;
Slichter, S ;
de Wildt-Eggen, J .
VOX SANGUINIS, 2003, 85 (03) :199-205